Stocks · Health care · Biological Products, (No Diagnostic Substances)

Relay Therapeutics, Inc.

RLAY Clue Score52
United States Fiscal year ends December CIK 0001812364 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Donald A Bergstrom
22 Jun 2026
President, R&D
Sold after exercise
93,456
$16.94
$1.58M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
51,560
$16.97
$874.97K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
61,563
$16.97
$1.04M
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
56,323
$16.97
$955.80K
Thomas Catinazzo
22 Jun 2026
Chief Financial Officer
Sold after exercise
17,717
$17.01
$301.37K
Thomas Catinazzo
9 Apr 2026
Chief Financial Officer
Sold after exercise
1,800
$15.00
$27.00K

What was left out

Form 4 filings counted 44
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 16
Sales straight out of an exercise 6
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020